Vir Biotechnology, Inc

(NASDAQ:VIR)

Latest On Vir Biotechnology, Inc (VIR):

Date/Time Type Description Signal Details
2023-05-04 20:30 ESTNewsVir Biotechnology GAAP EPS of -$1.06, revenue of $63MN/A
2023-03-22 21:45 ESTNewsVectoring In On Vir BiotechnologyN/A
2023-03-06 08:52 ESTNewsVir gains as JPMorgan upgrades on flu and Hep B candidatesN/A
2023-02-23 23:34 ESTNewsVir Biotechnology GAAP EPS of -$0.76 misses by $0.42, revenue of $49.4M misses by $84.84MN/A
2023-02-23 23:34 ESTNewsVir Biotechnology loses 5% following Q4 2022 earnings missesN/A
2023-02-22 21:26 ESTNewsVir Biotechnology Q4 2022 Earnings PreviewN/A
2023-02-21 19:56 ESTNewsVir rises as Goldman Sachs upgrades to Buy citing post-COVID narrativeN/A
2023-02-16 22:31 ESTNewsVir Biotechnology names new CFON/A
2023-02-14 04:19 ESTNewsGlaxoSmithKline ends work with Vir Biotechnology on next-generation COVID treatmentsN/A
2023-02-01 11:58 ESTNewsGSK Q4 sales driven by vaccines as specialty medicines see decline; provides FY23 outlookN/A
2023-01-27 17:06 ESTNewsVir upgraded at Morgan Stanley citing multiple catalysts in 2023N/A
2023-01-25 11:51 ESTNewsVir Biotechnology CEO George Scangos to retireN/A
2023-01-19 14:07 ESTNewsVir Biotechnology: High Potential Returns With High Volatility RisksN/A
2023-01-13 17:52 ESTNewsWHO updates COVID-19 guidelines on masks, treatmentsN/A
2023-01-08 10:19 ESTNewsVir Biotechnology: The First Entry In My Long Term Value PortfolioN/A
2022-12-18 01:10 ESTNewsVir Biotechnology: Collaborative Approach To Taking On Serious DiseasesN/A
2022-11-14 20:08 ESTNewsGates Foundation added LumiraDX, pared Atreca stake in Q3N/A
2022-11-11 22:37 ESTNewsVir Biotechnology (VIR) Presents at AASLD The Liver Meeting 2022N/A
2022-11-03 20:40 ESTNewsVir Biotechnology GAAP EPS of $1.30 beats by $1.37, revenue of $374.6M beats by $260.32MN/A
2022-11-03 20:40 ESTNewsVir Biotechnology rises after hours as GSK collaboration revenue leads to big Q3 beatN/A
2022-11-03 03:28 ESTNewsVir Biotechnology Q3 2022 Earnings PreviewN/A
2022-11-02 11:11 ESTNewsGSK raises FY22 outlook as Q3 sales grow on Specialty Medicines, ShingrixN/A
2022-10-12 14:35 ESTNewsVir Biotechnology: Focus On Hepatitis B Development Could End Up Paying OffN/A
2022-10-04 10:58 ESTNewsVir Biotech gains 12% as U.S. govt. inks multi-year deal worth up to $1BN/A
2022-09-23 03:54 ESTNewsVir begins dosing in mid-stage study of VIR-2218, VIR-3434 for hepatitis D virusN/A
2022-09-16 20:51 ESTNewsWHO advises against use of GSK/Vir, Regeneron COVID drugs, backs limited use of Gilead's remdesivirN/A
2022-08-10 10:11 ESTNewsVir Biotechnology GAAP EPS of -$0.58 misses by $0.84N/A
2022-08-10 10:11 ESTNewsVir Biotechnology falls 15% on Q2 revenue miss impacted by ~$400M for potential write-offsN/A
2022-08-04 05:58 ESTNewsVir Biotechnology Q2 2022 Earnings PreviewN/A
2022-07-28 03:54 ESTNewsVir: Biotechnology's Best Near-Term Capital Gain ProspectN/A
2022-07-27 13:46 ESTNewsGSK boosts FY22 outlook while Q2 sales soar on Shingrix, Specialty drugs; sees impact on COVID products in H2N/A
2022-06-27 21:12 ESTNewsVir Biotechnology reports data from Hepatitis B programN/A
2022-05-22 06:14 ESTNewsVir slips as collaboration with WuXi for COVID-19 antibody drug endsN/A
2022-05-05 17:40 ESTNewsVir Biotechnology GAAP EPS of $3.85 beats by $0.31, revenue of $1.23B beats by $418.95MN/A
2022-05-04 18:53 ESTNewsVir Biotechnology Q1 2022 Earnings PreviewN/A
2022-05-03 07:08 ESTNewsVir Biotechnology: Expanded Hepatitis Pipeline And COVID-19 Revenue ExpectedN/A
2022-04-07 17:50 ESTNewsVir Biotechnology appoints Johanna Friedl-Naderer to COON/A
2022-04-06 10:06 ESTNewsGlaxoSmithKline, Vir COVID-19 therapy is no longer authorized in U.S. - FDAN/A
2022-03-30 12:09 ESTNewsCamden Property Trust heads to S&P 500; VIR moves up on index changeN/A
2022-03-29 17:59 ESTNewsUS agency pauses distribution of GSK, Vir's COVID-19 therapy sotrovimab in certain statesN/A
2022-03-26 22:01 ESTNewsLong COVID, the next frontier for vaccine and drug developersN/A
2022-03-26 22:00 ESTNewsGlaxoSmithKline, Vir hit by amended authorization for COVID-19 antibody therapy in U.S.N/A
2022-03-23 23:35 ESTNewsMore contagious Omicron subvariant makes up over a third of U.S. COVID-19 cases - CDCN/A
2022-03-15 14:22 ESTNewsU.S. faces a shortage of COVID-19 antibody therapies without more funds - White HouseN/A
2022-03-09 00:40 ESTNewsMore contagious Omicron sub-variant makes up over a tenth of COVID variants in U.S. - CDCN/A
2022-03-07 13:32 ESTNewsVir Biotechnology (VIR) Investor Presentation - SlideshowN/A
2022-03-03 22:48 ESTNewsVir Biotech upgraded at Baird citing recent weaknessN/A
2022-02-25 02:10 ESTNewsVir Biotechnology GAAP EPS of $3.92 beats by $1.29, revenue of $812.7M beats by $189.8MN/A
2022-02-24 06:30 ESTNewsVir Biotechnology Q4 2021 Earnings PreviewN/A
2022-02-24 06:30 ESTNewsGlaxoSmithKline-Vir's COVID therapy use limited by FDA - ReutersN/A

About Vir Biotechnology, Inc (VIR):

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.

VIR Quotes by TradingView

See Advanced Chart

General

  • Name Vir Biotechnology, Inc
  • Symbol VIR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 327
  • Fiscal Year EndDecember
  • IPO Date2019-10-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.vir.bio
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 82.42
  • Price/Book (Most Recent Quarter) 9.42
  • Enterprise Value Revenue 79.69
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.31
  • Next Year EPS Estimate -$0.72
  • Next Quarter EPS Estimate -$0.69
  • Operating Margin -350%
  • Return on Assets -23%
  • Return on Equity -52%
  • Revenue 76.37 million
  • Earnings Per Share -$5.76
  • Revenue Per Share $0.64
  • Gross Profit -196511000
  • Quarterly Earnings Growth 76.9%
View More

Highlights

  • Market Capitalization 7.18 billion
  • EBITDA -126076000
  • PE Ratio -1.78
  • Analyst Target Price $88.4
View More

Share Statistics

  • Shares Outstanding 127.39 million
  • Shares Float 60.51 million
  • % Held by Insiders 1416%
  • % Held by Institutions 79.61%
  • Shares Short 8.11 million
  • Shares Short Prior Month 8.44 million
  • Short Ratio 3.32
  • Short % of Float 13%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $83.5
  • 52 Week Low $25.31
  • 50 Day Moving Average 62.25
  • 200 Day Moving Average 40.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Vir Biotechnology, Inc (VIR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Vir Biotechnology, Inc (VIR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.83-$0.70-18.86%
2020-09-302020-11-10$N/A-$0.67-$0.60-12.02%
2020-06-302020-08-11$66.99 million-$0.27-$0.6256.19%
2020-03-312020-05-12$5.72 million-$0.71-$0.56-27.51%
2019-12-312020-03-26$980000-$0.69-$0.63-10.1%
2019-09-302019-11-19$1.4 million-$4.60-$3.34-37.93%

Vir Biotechnology, Inc (VIR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Vir Biotechnology, Inc (VIR) Chart:

Vir Biotechnology, Inc (VIR) News:

Below you will find a list of latest news for Vir Biotechnology, Inc (VIR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Vir Biotechnology, Inc (VIR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0540.13TRUE00
2024-05-1753.46CALL0 2323.07TRUE00
2024-05-177.50.88CALL0 1996.6TRUE00
2024-05-17100.14CALL1 22978.85FALSE0.040.4
2024-05-1712.50.25CALL0 5030FALSE00
2024-05-17150.2CALL0 10FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-1722.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.50.3PUT0 12265.56FALSE00
2024-05-17101.84PUT10 152161.16TRUE1.840
2024-05-1712.50PUT0 0217.04TRUE00
2024-05-17150PUT0 0290.16TRUE00
2024-05-1717.50PUT0 0304.25TRUE00
2024-05-17200PUT0 0362.63TRUE00
2024-05-1722.50PUT0 0306.34TRUE00
2024-06-212.50CALL0 0363.81TRUE00
2024-06-2150CALL0 0233.49TRUE00
2024-06-217.50CALL0 067.44TRUE00
2024-06-21100.3CALL1 465.41FALSE0.050.2
2024-06-2112.50.09CALL1 071.99FALSE0.090
2024-06-21150CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 064.58FALSE00
2024-06-21100PUT0 072.25TRUE00
2024-06-2112.50PUT0 0177.64TRUE00
2024-06-21150PUT0 0207.95TRUE00
2024-07-192.56.6CALL0 4276.39TRUE00
2024-07-1956.1CALL0 5118.77TRUE00
2024-07-197.52.15CALL0 11454.09TRUE00
2024-07-19100.43CALL0 55656.9FALSE00
2024-07-1912.50.1CALL0 126863.6FALSE00
2024-07-19150.05CALL0 11578.15FALSE00
2024-07-1917.50.3CALL0 1510FALSE00
2024-07-19200.15CALL0 10FALSE00
2024-07-1922.50CALL0 00FALSE00
2024-07-192.50PUT0 00FALSE00
2024-07-1950.15PUT0 280FALSE00
2024-07-197.50.61PUT0 132866.19FALSE00
2024-07-19101.95PUT0 8861.02TRUE00
2024-07-1912.52.15PUT0 109120.93TRUE00
2024-07-19154.2PUT0 2797.01TRUE00
2024-07-1917.50PUT0 0168.61TRUE00
2024-07-19200PUT0 0160.46TRUE00
2024-07-1922.50PUT0 0220.48TRUE00
2024-10-182.50CALL0 0197.3TRUE00
2024-10-1850CALL0 085.22TRUE00
2024-10-187.51.75CALL0 380.7TRUE00
2024-10-18100.9CALL2 14664.2FALSE0.030.03
2024-10-1812.50.4CALL0 15264.91FALSE00
2024-10-18150.42CALL0 21763.15FALSE00
2024-10-1817.50.5CALL0 973.97FALSE00
2024-10-18200.1CALL0 6050FALSE00
2024-10-1822.50.29CALL0 510FALSE00
2024-10-182.50PUT0 00FALSE00
2024-10-1850PUT0 076.82FALSE00
2024-10-187.51.1PUT0 4462.71FALSE00
2024-10-18101.36PUT0 2764.98TRUE00
2024-10-1812.53.55PUT0 673.31TRUE00
2024-10-18150PUT0 0118.96TRUE00
2024-10-1817.50PUT0 0123.79TRUE00
2024-10-18200PUT0 0127.79TRUE00
2024-10-1822.50PUT0 0168.46TRUE00

Latest VIR Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$22.11
Jun 13, 2022 7:59 PM EST3$22.13
Jun 13, 2022 7:59 PM EST100$22.12
Jun 13, 2022 7:59 PM EST100$22.11
Jun 13, 2022 7:59 PM EST11$22.09

Vir Biotechnology, Inc (VIR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm
2020-06-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1706431/000000000020005785/0000000000-20-005785-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089843219001252/0000898432-19-001252-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089843219001253/0000898432-19-001253-index.htm
2019-12-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000089843219001340/0000898432-19-001340-index.htm
2020-05-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000089843220000544/0000898432-20-000544-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025486/0000899243-19-025486-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025488/0000899243-19-025488-index.htm
2019-10-163/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025640/0000899243-19-025640-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025695/0000899243-19-025695-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025766/0000899243-19-025766-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000089924319025772/0000899243-19-025772-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000090342319000327/0000903423-19-000327-index.htm
2020-06-23DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1706431/000095012320006355/0000950123-20-006355-index.htm
2019-11-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1706431/000107261319000288/0001072613-19-000288-index.htm
2020-07-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1706431/000107261320000244/0001072613-20-000244-index.htm
2019-10-11424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1706431/000119312519266864/0001193125-19-266864-index.htm
2019-10-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1706431/000119312519267739/0001193125-19-267739-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312519268465/0001193125-19-268465-index.htm
2019-10-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000119312519274796/0001193125-19-274796-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520012408/0001193125-20-012408-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520018960/0001193125-20-018960-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520033376/0001193125-20-033376-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000119312520038186/0001193125-20-038186-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000119312520038518/0001193125-20-038518-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520067291/0001193125-20-067291-index.htm
2020-03-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1706431/000119312520087036/0001193125-20-087036-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520098942/0001193125-20-098942-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520100575/0001193125-20-100575-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520103108/0001193125-20-103108-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520127710/0001193125-20-127710-index.htm
2020-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1706431/000119312520137555/0001193125-20-137555-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520150065/0001193125-20-150065-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520155704/0001193125-20-155704-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520169350/0001193125-20-169350-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520174259/0001193125-20-174259-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520187279/0001193125-20-187279-index.htm
2020-07-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1706431/000119312520187304/0001193125-20-187304-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1706431/000119312520187358/0001193125-20-187358-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1706431/000119312520187359/0001193125-20-187359-index.htm
2020-07-07S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1706431/000119312520189005/0001193125-20-189005-index.htm
2020-07-08POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1706431/000119312520189006/0001193125-20-189006-index.htm
2020-07-08424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1706431/000119312520189707/0001193125-20-189707-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520213032/0001193125-20-213032-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520237218/0001193125-20-237218-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000119312520247168/0001193125-20-247168-index.htm
2019-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052974/0001209191-19-052974-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052975/0001209191-19-052975-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052977/0001209191-19-052977-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052978/0001209191-19-052978-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052979/0001209191-19-052979-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119052981/0001209191-19-052981-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053065/0001209191-19-053065-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053066/0001209191-19-053066-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053067/0001209191-19-053067-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053661/0001209191-19-053661-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053662/0001209191-19-053662-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/0001209191-19-053663-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053664/0001209191-19-053664-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053665/0001209191-19-053665-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119053666/0001209191-19-053666-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919119060214/0001209191-19-060214-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120013608/0001209191-20-013608-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120024672/0001209191-20-024672-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120025177/0001209191-20-025177-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm
2020-05-074/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120027806/0001209191-20-027806-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032059/0001209191-20-032059-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032060/0001209191-20-032060-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032061/0001209191-20-032061-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032062/0001209191-20-032062-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032063/0001209191-20-032063-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032064/0001209191-20-032064-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032065/0001209191-20-032065-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032066/0001209191-20-032066-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120038511/0001209191-20-038511-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120039103/0001209191-20-039103-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm
2020-07-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120042452/0001209191-20-042452-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120042454/0001209191-20-042454-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120042489/0001209191-20-042489-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm
2020-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120044060/0001209191-20-044060-index.htm
2020-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm
2020-08-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120044531/0001209191-20-044531-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120044534/0001209191-20-044534-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120045693/0001209191-20-045693-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-09-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120048971/0001209191-20-048971-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120048972/0001209191-20-048972-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120049967/0001209191-20-049967-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120052221/0001209191-20-052221-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054735/0001209191-20-054735-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054736/0001209191-20-054736-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054737/0001209191-20-054737-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054738/0001209191-20-054738-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054739/0001209191-20-054739-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054740/0001209191-20-054740-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054741/0001209191-20-054741-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054742/0001209191-20-054742-index.htm
2020-10-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054743/0001209191-20-054743-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000120919120057160/0001209191-20-057160-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1706431/000138713120004398/0001387131-20-004398-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000156459019043876/0001564590-19-043876-index.htm
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1706431/000156459019043877/0001564590-19-043877-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000156459020013184/0001564590-20-013184-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1706431/000156459020013194/0001564590-20-013194-index.htm
2020-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1706431/000156459020015537/0001564590-20-015537-index.htm
2020-04-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1706431/000156459020015538/0001564590-20-015538-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1706431/000156459020024651/0001564590-20-024651-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000156459020024652/0001564590-20-024652-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1706431/000156459020039291/0001564590-20-039291-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1706431/000156459020039295/0001564590-20-039295-index.htm
2020-05-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000178633520000001/0001786335-20-000001-index.htm
2020-05-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1706431/000178633520000002/0001786335-20-000002-index.htm
2019-10-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1706431/999999999519002288/9999999995-19-002288-index.htm
2020-07-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1706431/999999999520001710/9999999995-20-001710-index.htm

Vir Biotechnology, Inc (VIR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vir Biotechnology, Inc (VIR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1416%
Institutional Ownership: 7961%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-14Herbert VirginEVP, Research & CSOSell3,805.0030.07114,418.250.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm
2020-05-18Herbert VirginEVP, Research & CSOSell1,755.0038.0066,690.000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm
2020-05-26Herbert VirginEVP, Research & CSOSell3,805.0034.08129,674.400.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm
2020-06-09Herbert VirginEVP, Research & CSOSell3,805.0036.28138,030.180.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm
2020-06-19Herbert VirginEVP, Research & CSOSell1,755.0038.0066,690.000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm
2020-06-23Herbert VirginEVP, Research & CSOSell5,560.0038.99216,777.730.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm
2020-06-24Herbert VirginEVP, Research & CSOSell9,360.0048.00449,280.000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm
2020-07-14Herbert VirginEVP, Research & CSOSell7,900.0048.85385,876.290.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm
2020-07-28Herbert VirginEVP, Research & CSOSell7,900.0047.99379,090.190.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm
2020-08-11Herbert VirginEVP, Research & CSOSell7,900.0051.08403,562.810.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm
2019-10-16ARCH Venture Partners IX, LLC10% Share HolderBuy1,000,000.0020.0020,000,000.001,000,000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919119053664/0001209191-19-053664-index.htm
2019-10-16Kristina BurowDirectorBuy1,000,000.0020.0020,000,000.001,000,000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919119053666/0001209191-19-053666-index.htm
2019-10-16ROBERT NELSENDirectorBuy1,000,000.0020.0020,000,000.001,000,000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919119053665/0001209191-19-053665-index.htm
2020-04-17Phillip PangChief Medical OfficerBuy8,000.000.866,840.0015,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120025177/0001209191-20-025177-index.htm
2020-06-03Phillip PangChief Medical OfficerSell7,500.0035.06262,932.0015,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm
2020-06-17Phillip PangChief Medical OfficerSell7,500.0037.26279,472.5015,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm
2020-07-01Phillip PangChief Medical OfficerSell5,000.0037.77188,840.5015,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm
2020-07-15Phillip PangChief Medical OfficerSell7,500.0049.52371,435.2515,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm
2020-08-05Phillip PangChief Medical OfficerSell7,500.0050.89381,695.2515,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm
2020-05-18Herbert VirginEVP, Research & CSOBuy1,755.001.532,685.151,755.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm
2020-06-19Herbert VirginEVP, Research & CSOSell1,755.0038.0066,694.041,755.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm
2020-07-13Howard HornCFOSell30,000.0050.061,501,731.00177,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042489/0001209191-20-042489-index.htm
2020-07-01Phillip PangChief Medical OfficerBuy2,778.001.584,375.3518,555.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm
2020-09-08Herbert VirginEVP, Research & CSOSell2,340.0029.9870,147.5820,000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm
2020-09-22Herbert VirginEVP, Research & CSOSell3,805.0031.71120,638.2920,000.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm
2020-07-02Howard HornCFOSell10,000.0040.00400,000.00207,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm
2020-07-01Howard HornCFOSell400.0039.3315,732.00217,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm
2020-07-01Howard HornCFOSell500.0038.7819,392.00218,177.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm
2020-07-01Howard HornCFOSell9,100.0037.72343,274.75218,677.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm
2020-05-14Jay ParrishChief Business OfficerSell75,000.0030.052,253,885.00222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm
2020-06-01Jay ParrishChief Business OfficerSell75,000.0035.222,641,410.00222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm
2020-07-01Jay ParrishChief Business OfficerSell75,000.0037.952,846,310.00222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm
2020-08-03Jay ParrishChief Business OfficerSell11,110.0047.65529,403.72222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm
2020-09-01Jay ParrishChief Business OfficerSell6,943.0039.15271,796.23222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm
2020-10-01Jay ParrishChief Business OfficerSell6,945.0034.75241,341.53222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm
2020-11-02Jay ParrishChief Business OfficerSell6,944.0031.27217,152.77222,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm
2020-09-08Herbert VirginEVP, Research & CSOSell1,465.0030.0043,950.0022,340.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm
2019-10-16Endurance (Cayman) Ltd SVF10% Share HolderBuy950,000.0020.0019,000,000.0022,616,666.00https://www.sec.gov/Archives/edgar/data/1706431/000089924319025695/0000899243-19-025695-index.htm
2020-11-02Jay ParrishChief Business OfficerBuy4,629.001.496,874.07226,851.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm
2020-10-01Jay ParrishChief Business OfficerBuy4,630.001.496,875.55226,852.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm
2020-06-25Howard HornCFOSell30,000.0050.001,500,000.00227,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120039103/0001209191-20-039103-index.htm
2020-09-01Jay ParrishChief Business OfficerBuy6,943.001.5810,935.23229,165.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm
2020-11-02Jay ParrishChief Business OfficerBuy2,315.001.583,646.13229,166.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm
2020-10-01Jay ParrishChief Business OfficerBuy2,315.001.583,646.13229,167.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm
2020-08-03Jay ParrishChief Business OfficerBuy9,259.001.4913,749.62231,481.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm
2020-06-03Phillip PangChief Medical OfficerSell5,000.0035.09175,455.0023,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm
2020-06-17Phillip PangChief Medical OfficerSell5,000.0037.27186,342.0023,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm
2020-07-01Phillip PangChief Medical OfficerSell7,500.0037.79283,411.5023,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm
2020-07-15Phillip PangChief Medical OfficerSell5,000.0049.54247,683.0023,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm
2020-08-05Phillip PangChief Medical OfficerSell5,000.0050.91254,526.5023,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm
2020-08-03Jay ParrishChief Business OfficerBuy1,851.001.582,915.33233,332.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm
2020-09-24Herbert VirginEVP, Research & CSOBuy3,700.001.535,661.0023,700.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120052221/0001209191-20-052221-index.htm
2020-09-29Herbert VirginEVP, Research & CSOSell3,510.0038.00133,380.0023,700.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm
2020-10-13Herbert VirginEVP, Research & CSOSell5,560.0043.03239,236.2423,700.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm
2020-10-27Herbert VirginEVP, Research & CSOSell3,805.0035.04133,334.8123,700.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm
2020-09-08Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.6523,805.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm
2020-09-22Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.6523,805.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm
2020-07-01Jay ParrishChief Business OfficerBuy25,925.001.4938,498.63248,147.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm
2020-06-19Howard HornCFOSell10,000.0040.00400,000.00257,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038511/0001209191-20-038511-index.htm
2020-08-19Phillip PangChief Medical OfficerBuy10,185.001.5816,041.3825,962.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-07-15Phillip PangChief Medical OfficerBuy10,186.001.5816,042.9525,963.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm
2020-06-01Howard HornCFOSell6,714.0035.38237,572.88267,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm
2020-09-29Herbert VirginEVP, Research & CSOBuy3,510.001.535,370.3027,210.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm
2020-06-01Howard HornCFOSell3,286.0034.53113,465.25274,491.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm
2020-10-27Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.6527,505.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm
2020-06-03Phillip PangChief Medical OfficerBuy12,500.005.1864,687.5028,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm
2020-06-17Phillip PangChief Medical OfficerBuy12,500.005.1864,687.5028,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm
2020-07-01Phillip PangChief Medical OfficerBuy9,722.005.1850,311.3528,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm
2020-07-15Phillip PangChief Medical OfficerBuy2,314.005.1811,974.9528,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm
2020-08-05Phillip PangChief Medical OfficerBuy12,500.001.5819,687.5028,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm
2020-08-19Phillip PangChief Medical OfficerBuy2,315.005.1811,980.1328,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-10-13Herbert VirginEVP, Research & CSOBuy5,560.001.538,506.8029,260.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm
2020-05-14Jay ParrishChief Business OfficerBuy75,000.001.49111,375.00297,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm
2020-06-01Jay ParrishChief Business OfficerBuy75,000.001.49111,375.00297,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm
2020-07-01Jay ParrishChief Business OfficerBuy49,075.001.5877,293.13297,222.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm
2020-08-19Phillip PangChief Medical OfficerSell7,500.0050.94382,047.7529,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-09-02Phillip PangChief Medical OfficerSell5,000.0032.91164,537.0029,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm
2020-09-16Phillip PangChief Medical OfficerSell5,000.0031.92159,591.0029,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-10-07Phillip PangChief Medical OfficerSell5,000.0041.73208,629.0029,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm
2020-10-21Phillip PangChief Medical OfficerSell5,000.0035.59177,951.5029,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2020-11-04Phillip PangChief Medical OfficerBuy5,000.001.537,650.0034,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120057160/0001209191-20-057160-index.htm
2020-09-02Phillip PangChief Medical OfficerSell7,500.0032.88246,621.7534,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm
2020-09-16Phillip PangChief Medical OfficerSell7,500.0031.88239,103.0034,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-10-07Phillip PangChief Medical OfficerSell7,500.0041.76313,166.2534,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm
2020-10-21Phillip PangChief Medical OfficerSell7,500.0035.42265,656.7534,777.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2020-06-19Herbert VirginEVP, Research & CSOBuy3,510.001.535,370.303,510.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm
2019-10-16Dhabi Investment Authority AbuInsiderBuy1,000,000.0020.0020,000,000.003,666,666.00https://www.sec.gov/Archives/edgar/data/1706431/000090342319000327/0000903423-19-000327-index.htm
2020-08-19Phillip PangChief Medical OfficerSell5,000.0050.96254,807.5037,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-10-21Phillip PangChief Medical OfficerBuy7,870.001.5312,041.1037,647.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2020-05-14Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.653,805.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm
2020-05-26Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.653,805.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm
2020-06-09Herbert VirginEVP, Research & CSOBuy3,805.001.535,821.653,805.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm
2020-09-16Phillip PangChief Medical OfficerBuy9,720.001.5815,309.0039,497.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-09-16Phillip PangChief Medical OfficerBuy465.001.53711.4539,962.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-10-07Phillip PangChief Medical OfficerBuy10,185.001.5315,583.0539,962.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm
2020-10-21Phillip PangChief Medical OfficerBuy2,315.001.583,646.1339,962.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2020-08-19Phillip PangChief Medical OfficerBuy14,000.000.8611,970.0042,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm
2020-09-02Phillip PangChief Medical OfficerBuy12,500.001.5819,687.5042,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm
2020-09-16Phillip PangChief Medical OfficerBuy2,315.005.1811,980.1342,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm
2020-10-07Phillip PangChief Medical OfficerBuy2,315.001.583,646.1342,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm
2020-10-21Phillip PangChief Medical OfficerBuy2,315.005.1811,980.1342,277.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm
2019-10-16Holdings (Private) Ltd Temasek10% Share HolderBuy500,000.0020.0010,000,000.005,499,999.00https://www.sec.gov/Archives/edgar/data/1706431/000089924319025766/0000899243-19-025766-index.htm
2019-10-16Permanent Fund Corp Alaska10% Share HolderBuy1,500,000.0020.0030,000,000.005,555,556.00https://www.sec.gov/Archives/edgar/data/1706431/000089843219001253/0000898432-19-001253-index.htm
2020-06-23Herbert VirginEVP, Research & CSOBuy5,560.001.538,506.805,560.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm
2020-05-01ROBERT J MOREDirectorSell2,700.0028.6077,212.4471,534.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm
2020-05-01ROBERT J MOREDirectorSell15,758.0027.90439,640.3274,234.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm
2020-07-14Herbert VirginEVP, Research & CSOBuy7,900.001.5312,087.007,900.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm
2020-07-28Herbert VirginEVP, Research & CSOBuy7,900.001.5312,087.007,900.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm
2020-08-11Herbert VirginEVP, Research & CSOBuy7,900.001.5312,087.007,900.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm
2020-06-24Herbert VirginEVP, Research & CSOBuy9,360.001.5314,320.809,360.00https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm